TScan Therapeutics, Inc.
TCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001783328
No open-market purchases or sales by TScan Therapeutics, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $35.1M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding TScan Therapeutics, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 61 | 1 | 60 | 0 |
| Shares | 30.7M | 2.48M | 32.5M | +4.29M (+15.2%) |
| Value | $30.7M | $2.48M | $32.8M | +$4.60M (+16.3%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held TScan Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 2,154,256 | $2.18M | 0.00% |
| Vanguard Fiduciary Trust Co | 305,772 | $308.8K | 0.00% |
| Verdad Advisers, LP | 134,001 | $135.3K | 0.15% |
| Kestra Advisory Services, LLC | 62,525 | $63.1K | 0.00% |
| Ameriprise Financial Inc | 52,635 | $53.2K | 0.00% |
| Nine Masts Capital Ltd | 41,740 | $42.2K | 0.01% |
| Public Employees Retirement System of Ohio | 27,700 | $28.0K | 0.00% |
| Virtu Financial LLC | 18,140 | $18.0K | 0.00% |
| Vanguard Global Advisers, LLC | 15,705 | $15.9K | 0.00% |
| Caitong International Asset Management Co., Ltd | 2 | $2 | 0.00% |
| Citigroup Inc | 1 | $1 | 0.00% |
Sold out (11)
Institutions that held TScan Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Two Sigma Advisers, LP | 353,900 | $353.9K |
| Tang Capital Management LLC | 46,131 | $46.1K |
| HRT Financial LP | 26,581 | $26.0K |
| Neuberger Berman Group LLC | 18,400 | $18.4K |
| R Squared Ltd | 16,033 | $16.0K |
| Two Sigma Securities, LLC | 15,942 | $15.9K |
| Point72 Asset Management, L.P. | 14,512 | $14.5K |
| Mizuho Securities USA LLC | 10,000 | $10.1K |
| Waldron Private Wealth LLC | 10,000 | $10.0K |
| Rockefeller Capital Management L.P. | 200 | $200 |
| Northwestern Mutual Wealth Management Co | 8 | $8 |
Not filed for Q1 2026 yet (1)
Institutions that held TScan Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 2,475,733 | $2.48M |